We are live on ! Find out more
LEGN icon

Legend Biotech
LEGN

77 hedge funds and large institutions have $1.04B invested in Legend Biotech in 2020 Q2 according to their latest regulatory filings, with 77 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

9.32% more ownership

Funds ownership: 0% → 9.32% (+9.3%)

Holders
77
Holders Change
+77
Holders Change %
–
% of All Funds
1.58%
Holding in Top 10
4
Holding in Top 10 Change
+4
Holding in Top 10 Change %
% of All Funds
0.08%
New
77
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VC
Vivo Capital
California
+$139M
2
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
+$119M
3
RCM
RA Capital Management
Massachusetts
+$97M
4
CII
Capital International Inc
California
+$78.9M
5
JJIJ
Johnson & Johnson Innovation - JJDC
New Jersey
+$63.6M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Jennison Associates
26
Jennison Associates
New York
$5.75M +$5.27M +135,000 New
BG
27
Bellevue Group
Switzerland
$5.71M +$5.25M +134,261 New
TCM
28
TimesSquare Capital Management
New York
$5.71M +$5.24M +134,100 New
ICP
29
Indus Capital Partners
New York
$5.28M +$4.85M +124,100 New
APM
30
Avidity Partners Management
Texas
$4.26M +$3.91M +100,000 New
SC
31
Samlyn Capital
New York
$4.26M +$3.91M +100,000 New
SCM
32
Suvretta Capital Management
New York
$4.26M +$3.91M +100,000 New
JCAM
33
Jericho Capital Asset Management
New York
$4.09M +$3.75M +96,000 New
CCM
34
CAAS Capital Management
New York
$3.4M +$3.13M +80,000 New
HM
35
HealthCor Management
New York
$3.19M +$2.93M +75,000 New
UOC
36
UBS O'Connor
Illinois
$2.79M +$2.57M +65,672 New
Alyeska Investment Group
37
Alyeska Investment Group
Illinois
$2.15M +$1.97M +50,400 New
ACH
38
ArrowMark Colorado Holdings
Colorado
$2.13M +$1.95M +50,000 New
MIM
39
Monashee Investment Management
Massachusetts
$2.13M +$1.95M +50,000 New
Invesco
40
Invesco
Georgia
$2.13M +$1.95M +50,001 New
MWNA
41
Marshall Wace North America
New York
$2.07M +$1.9M +48,613 New
Jane Street
42
Jane Street
New York
$1.88M +$1.73M +44,171 New
ECM
43
ExodusPoint Capital Management
New York
$1.72M +$1.58M +40,451 New
VIA
44
Vident Investment Advisory
Georgia
$1.56M +$1.44M +36,735 New
Citadel Advisors
45
Citadel Advisors
Florida
$1.29M +$1.19M +30,359 New
PCM
46
Pinz Capital Management
New York
$1.28M +$1.17M +30,000 New
Morgan Stanley
47
Morgan Stanley
New York
$1.26M +$1.16M +29,658 New
CM
48
Crestline Management
Texas
$1.06M +$977K +25,000 New
PA
49
Perceptive Advisors
New York
$1.06M +$977K +25,000 New
UBS AM
50
UBS AM
Illinois
$1.06M +$977K +25,000 New
1
2
3 4

LEGN Hedge Fund Activity: Q2 2020 in Review

77 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Legend Biotech (LEGN) for Q2 2020, worth a combined $1.04B.

Buyers outnumbered sellers: 77 funds opened new LEGN positions and 0 closed out — a net gain of 77 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Vivo Capital, opening a new position worth an estimated $139M.

  • 77 institutional investors held Legend Biotech (LEGN) as of Q2 2020, up from 0 in Q1 2020.
  • Funds reported $1.04B of Legend Biotech stock for Q2 2020.
  • 77 funds opened new Legend Biotech positions in Q2 2020 and 0 closed out, a net change of +77 holders.
  • The largest Legend Biotech buyer in Q2 2020 was Vivo Capital, an estimated $139M added.

Based on aggregated 13F filings for Q2 2020.